Stockreport

Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)

Gritstone bio, Inc.  (GRTS) 
Last gritstone bio, inc. earnings: 11/12 09:01 am Check Earnings Report
PDF -- Paper details vaccine design optimization process of Gritstone’s “off-the-shelf” or shared neoantigen vaccine platform, SLATE -- -- Discovery of a novel immunodomi [Read more]